wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37118663-9C099F77-5BE9-4FDD-A65F-575A87A17CE3
Q37118663-9C099F77-5BE9-4FDD-A65F-575A87A17CE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37118663-9C099F77-5BE9-4FDD-A65F-575A87A17CE3
Opportunities and challenges in combination gene cancer therapy.
P2860
Q37118663-9C099F77-5BE9-4FDD-A65F-575A87A17CE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37118663-9C099F77-5BE9-4FDD-A65F-575A87A17CE3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9368b68fec3b884f534cb11d6c4d092cde1b971f
P2860
BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia.